ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,468Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 1383

$929K Total Retail Price of All Prescriptions

Rank: 86 out of 1383

641 Patients Receiving at Least One Drug in Part D
81% Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Tennessee
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

8% of this provider’s 641 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

31% of this provider’s 641 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
FUROSEMIDE 1,687 1,602 169 1 7
POTASSIUM CHLORIDE 1,129 1,084 122 2 13
HYDROCODONE-ACETAMINOPHEN 889 732 182 S3 3 2
LISINOPRIL 791 698 117 4 3
WARFARIN SODIUM 788 758 53 5 16
OMEPRAZOLE 783 689 89 6 5
SIMVASTATIN 740 621 96 7 4
LEVOTHYROXINE SODIUM 652 589 84 8 1
GABAPENTIN 585 510 55 9 10
SERTRALINE HCL 515 429 69 10 22
METOPROLOL TARTRATE 493 488* 61 11 9
MIRTAZAPINE 446 441* 50 12 49
AMLODIPINE BESYLATE 409 361 62 13 6
DONEPEZIL HCL 389 366 37 14 39
ALPRAZOLAM 363 302 80 B 15 12
CLOPIDOGREL 347 319 45 16 17
METFORMIN HCL 340 293 73 17 8
CITALOPRAM HBR 305 274 49 18 18
ALLOPURINOL 302 271 24 19 36
PANTOPRAZOLE SODIUM 300 268 48 20 26
NAMENDA 266 266 16 21 41
TRAZODONE HCL 265 214 60 22 37
ATORVASTATIN CALCIUM 243 229 56 23 11
QUETIAPINE FUMARATE 239 216 15 A 24 55
FAMOTIDINE* 236 236 30 25 61
MELOXICAM 235 230* 27 26 21
CARVEDILOL 229 208 35 27 24
CYMBALTA 225 155 21 28 46
ESCITALOPRAM OXALATE 208 203* 18 29 57
NEXIUM 174 126 20 30 29
LORAZEPAM 173 168* 42 B 31 25
POLYETHYLENE GLYCOL 3350 168 149 47 32 67
METOLAZONE 166 166 22 33 195
METOPROLOL SUCCINATE 159 136 33 34 34
OXYBUTYNIN CHLORIDE 156 137 21 35 115
CIPROFLOXACIN HCL 154 140 88 36 59
LANTUS 152 129 30 37 60
RISPERIDONE 151 146* 12 A 38 75
ATENOLOL 145 112 29 39 19
FLUTICASONE PROPIONATE 142 113 59 40 38
LEVETIRACETAM 140 74 14 41 113
GLIPIZIDE 138 138 14 42 77
VESICARE 137 <11 <11 43 124
TEMAZEPAM 136 98 33 B 44 110
MONTELUKAST SODIUM 134 117 17 45 43
OXYBUTYNIN CHLORIDE ER 130 107 17 46 169
HYDROCHLOROTHIAZIDE 128 123* 26 47 14
NYSTATIN 128 123* 40 47 123
DIGOXIN 127 <11 <11 49 138
DIVALPROEX SODIUM 122 <11 <11 50 74
LOSARTAN POTASSIUM 118 113* 17 51 20
CYCLOBENZAPRINE HCL 117 93 24 R 52 82
HYDRALAZINE HCL 116 85 16 53 83
AMOX TR-POTASSIUM CLAVULANATE 113 99 58 54 104
PRAVASTATIN SODIUM 112 112 19 55 15
NYAMYC 112 107* 26 55 259
NIFEDIPINE ER 106 106 12 57 112
PROMETHAZINE HCL 104 81 48 R 58 71
AZITHROMYCIN 103 77 86 59 52
RIVASTIGMINE 100 <11 <11 60 207
LOVASTATIN 100 84 24 60 31
ALENDRONATE SODIUM 99 94* 17 62 48
PREDNISONE 98 85 47 63 44
CLONAZEPAM 98 39 13 B 63 42
DIAZEPAM 97 79 14 B 65 62
CEPHALEXIN 95 82 61 66 91
ISOSORBIDE MONONITRATE ER 94 94 12 67 69
NITROFURANTOIN MONO-MACRO 93 88* 39 68 219
TRAMADOL HCL 84 71 33 69 28
GLIMEPIRIDE 82 69 26 70 33
CLONIDINE HCL 81 66 26 71 50
IPRATROPIUM-ALBUTEROL 80 75* 34 72 128
TRIAMTERENE-HCTZ 78 65 21 73 53
SULFAMETHOXAZOLE-TRIMETHOPRIM 78 67 61 73 89
LYRICA 77 43 11 75 73
CARBIDOPA-LEVODOPA 76 71* 11 76 114
ROPINIROLE HCL 74 42 14 77 81
PAROXETINE HCL 74 <11 <11 77 58
JANUVIA 74 <11 <11 77 80
AMLODIPINE BESYLATE-BENAZEPRIL 73 <11 <11 80 79
ZOLPIDEM TARTRATE 73 55 27 80 27
PROAIR HFA 72 42 29 82 35
SPIRONOLACTONE 72 72 16 82 68
METOCLOPRAMIDE HCL 72 <11 <11 82 125
IBUPROFEN 71 52 16 85 93
TAMSULOSIN HCL 71 66* 18 85 32
DILTIAZEM ER 69 <11 <11 87 127
LABETALOL HCL 69 <11 <11 87 221
AMITRIPTYLINE HCL 68 <11 <11 R 89 70
RANITIDINE HCL 67 40 13 90 23
VENLAFAXINE HCL 67 <11 <11 90 182
LEVOFLOXACIN 67 53 51 90 76
GLIPIZIDE XL 66 <11 <11 93 242
PROPRANOLOL HCL 65 <11 <11 94 126
NITROFURANTOIN* 64 <11 <11 95 183
OLANZAPINE 64 <11 <11 A 95 135
MECLIZINE HCL 63 58* 16 97 111
BACLOFEN 62 49 17 98 99
BETHANECHOL CHLORIDE 61 <11 <11 99 399
AMIODARONE HCL 58 <11 <11 100 191
SUBOXONE 57 <11 <11 S3 101 145
AMOXICILLIN 57 45 46 101 116
BUDESONIDE 56 56 11 103 322
BUMETANIDE 56 <11 <11 103 133
KETOCONAZOLE 56 38 17 103 279
TIZANIDINE HCL 55 <11 <11 106 90
NYSTATIN-TRIAMCINOLONE 55 50* 32 106 363
NITROGLYCERIN PATCH 55 <11 <11 106 189
DILTIAZEM HCL 54 <11 <11 109 193
PHENYTOIN SODIUM EXTENDED 53 <11 <11 110 132
FINASTERIDE 53 <11 <11 110 117
KLOR-CON M20 52 47* 18 112 103
GALANTAMINE HBR 52 <11 <11 112 241
TRIAMCINOLONE ACETONIDE 52 41 35 112 150
BUPROPION HCL SR 51 <11 <11 115 184
OXCARBAZEPINE 51 <11 <11 115 290
TERAZOSIN HCL 50 <11 <11 117 131
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.